Literature DB >> 17178856

Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis.

Yun Gao1, Kyoko Kitagawa, Yoshihiro Hiramatsu, Hirotoshi Kikuchi, Tomoyasu Isobe, Mai Shimada, Chiharu Uchida, Takayuki Hattori, Toshiaki Oda, Keiko Nakayama, Keiichi I Nakayama, Tatsuo Tanaka, Hiroyuki Konno, Masatoshi Kitagawa.   

Abstract

A reduced expression level of the cyclin-dependent kinase inhibitor p27(Kip1) is associated with increased tumor malignancy and poor prognosis in individuals with various types of cancer. To investigate the basis for this relation, we applied microarray analysis to screen for genes differentially expressed between p27(+/-) and parental (p27(+/+)) HCT116 human colon carcinoma cells. Expression of the gene for G protein-coupled receptor 48 (GPR48) was increased in the p27(+/-) cells. Forced expression of GPR48 increased both in vitro invasive activity and lung metastasis potency of HCT116 cells. In contrast, depletion of endogenous GPR48 by RNA interference reduced the invasive potential of HeLa and Lewis lung carcinoma cells not only in vitro but also in vivo. Moreover, GPR48 expression was significantly associated with lymph node metastasis and inversely correlated with p27 expression in human colon carcinomas. GPR48 may thus play an important role in invasiveness and metastasis of carcinoma and might therefore represent a potential prognostic marker or therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178856     DOI: 10.1158/0008-5472.CAN-06-2629

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.

Authors:  Xi Wang; Ping Gao; Min Long; Fang Lin; Jun-Xia Wei; Ji-Hong Ren; Lin Yan; Ting He; Yuan Han; Hui-Zhong Zhang
Journal:  Med Oncol       Date:  2010-05-11       Impact factor: 3.064

Review 2.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

Review 3.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

4.  R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling.

Authors:  Kendra S Carmon; Xing Gong; Qiushi Lin; Anthony Thomas; Qingyun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-21       Impact factor: 11.205

5.  Intrinsic disorder in spondins and some of their interacting partners.

Authors:  Oluwole Alowolodu; Gbemisola Johnson; Lamis Alashwal; Iqbal Addou; Irina V Zhdanova; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-12-15

6.  GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.

Authors:  Fang Liang; Junmin Yue; Junyong Wang; Lijuan Zhang; Rui Fan; Hao Zhang; Qingsong Zhang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

7.  RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

Authors:  Kendra S Carmon; Xing Gong; Jing Yi; Anthony Thomas; Qingyun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

8.  Multi-functional norrin is a ligand for the LGR4 receptor.

Authors:  Cheng Deng; Pradeep Reddy; Yuan Cheng; Ching-Wei Luo; Chih-Lun Hsiao; Aaron J W Hsueh
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

9.  Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression.

Authors:  Yuhui Yuan; Li Qin; Dan Liu; Ray-Chang Wu; Paola Mussi; Suoling Zhou; Zhou Songyang; Jianming Xu
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

10.  LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.

Authors:  Jian Luo; Zhengfeng Yang; Yu Ma; Zhiying Yue; Hongyu Lin; Guojun Qu; Jinping Huang; Wentao Dai; Chenghai Li; Chunbing Zheng; Leqin Xu; Huaqing Chen; Jiqiu Wang; Dali Li; Stefan Siwko; Josef M Penninger; Guang Ning; Jianru Xiao; Mingyao Liu
Journal:  Nat Med       Date:  2016-04-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.